I forbindelse med behandlingen af patienter med BH4- defekt fremlagde virksomheden resultaterne af tre undersøgelser af sapropterindihydrochlorid fra faglitteraturen.
For the treatment of patients with BH4 deficiency, the company presented the results of three studies from the published literature with sapropterin dihydrochloride.